Inflammation and atherosclerosis: signaling pathways and therapeutic intervention

Abstract Atherosclerosis is a chronic inflammatory vascular disease driven by traditional and nontraditional risk factors. Genome-wide association combined with clonal lineage tracing and clinical trials have demonstrated that innate and adaptive immune responses can promote or quell atherosclerosis...

Full description

Bibliographic Details
Main Authors: Peng Kong, Zi-Yang Cui, Xiao-Fu Huang, Dan-Dan Zhang, Rui-Juan Guo, Mei Han
Format: Article
Language:English
Published: Nature Publishing Group 2022-04-01
Series:Signal Transduction and Targeted Therapy
Online Access:https://doi.org/10.1038/s41392-022-00955-7
_version_ 1818060615938211840
author Peng Kong
Zi-Yang Cui
Xiao-Fu Huang
Dan-Dan Zhang
Rui-Juan Guo
Mei Han
author_facet Peng Kong
Zi-Yang Cui
Xiao-Fu Huang
Dan-Dan Zhang
Rui-Juan Guo
Mei Han
author_sort Peng Kong
collection DOAJ
description Abstract Atherosclerosis is a chronic inflammatory vascular disease driven by traditional and nontraditional risk factors. Genome-wide association combined with clonal lineage tracing and clinical trials have demonstrated that innate and adaptive immune responses can promote or quell atherosclerosis. Several signaling pathways, that are associated with the inflammatory response, have been implicated within atherosclerosis such as NLRP3 inflammasome, toll-like receptors, proprotein convertase subtilisin/kexin type 9, Notch and Wnt signaling pathways, which are of importance for atherosclerosis development and regression. Targeting inflammatory pathways, especially the NLRP3 inflammasome pathway and its regulated inflammatory cytokine interleukin-1β, could represent an attractive new route for the treatment of atherosclerotic diseases. Herein, we summarize the knowledge on cellular participants and key inflammatory signaling pathways in atherosclerosis, and discuss the preclinical studies targeting these key pathways for atherosclerosis, the clinical trials that are going to target some of these processes, and the effects of quelling inflammation and atherosclerosis in the clinic.
first_indexed 2024-12-10T13:35:15Z
format Article
id doaj.art-e23e19e0d894461ea3f79497890eb41f
institution Directory Open Access Journal
issn 2059-3635
language English
last_indexed 2024-12-10T13:35:15Z
publishDate 2022-04-01
publisher Nature Publishing Group
record_format Article
series Signal Transduction and Targeted Therapy
spelling doaj.art-e23e19e0d894461ea3f79497890eb41f2022-12-22T01:46:51ZengNature Publishing GroupSignal Transduction and Targeted Therapy2059-36352022-04-017112410.1038/s41392-022-00955-7Inflammation and atherosclerosis: signaling pathways and therapeutic interventionPeng Kong0Zi-Yang Cui1Xiao-Fu Huang2Dan-Dan Zhang3Rui-Juan Guo4Mei Han5Department of Biochemistry and Molecular Biology, College of Basic Medicine, Key Laboratory of Medical Biotechnology of Hebei Province, Key Laboratory of Neural and Vascular Biology of Ministry of Education, Hebei Medical UniversityDepartment of Biochemistry and Molecular Biology, College of Basic Medicine, Key Laboratory of Medical Biotechnology of Hebei Province, Key Laboratory of Neural and Vascular Biology of Ministry of Education, Hebei Medical UniversityDepartment of Biochemistry and Molecular Biology, College of Basic Medicine, Key Laboratory of Medical Biotechnology of Hebei Province, Key Laboratory of Neural and Vascular Biology of Ministry of Education, Hebei Medical UniversityDepartment of Biochemistry and Molecular Biology, College of Basic Medicine, Key Laboratory of Medical Biotechnology of Hebei Province, Key Laboratory of Neural and Vascular Biology of Ministry of Education, Hebei Medical UniversityDepartment of Biochemistry and Molecular Biology, College of Basic Medicine, Key Laboratory of Medical Biotechnology of Hebei Province, Key Laboratory of Neural and Vascular Biology of Ministry of Education, Hebei Medical UniversityDepartment of Biochemistry and Molecular Biology, College of Basic Medicine, Key Laboratory of Medical Biotechnology of Hebei Province, Key Laboratory of Neural and Vascular Biology of Ministry of Education, Hebei Medical UniversityAbstract Atherosclerosis is a chronic inflammatory vascular disease driven by traditional and nontraditional risk factors. Genome-wide association combined with clonal lineage tracing and clinical trials have demonstrated that innate and adaptive immune responses can promote or quell atherosclerosis. Several signaling pathways, that are associated with the inflammatory response, have been implicated within atherosclerosis such as NLRP3 inflammasome, toll-like receptors, proprotein convertase subtilisin/kexin type 9, Notch and Wnt signaling pathways, which are of importance for atherosclerosis development and regression. Targeting inflammatory pathways, especially the NLRP3 inflammasome pathway and its regulated inflammatory cytokine interleukin-1β, could represent an attractive new route for the treatment of atherosclerotic diseases. Herein, we summarize the knowledge on cellular participants and key inflammatory signaling pathways in atherosclerosis, and discuss the preclinical studies targeting these key pathways for atherosclerosis, the clinical trials that are going to target some of these processes, and the effects of quelling inflammation and atherosclerosis in the clinic.https://doi.org/10.1038/s41392-022-00955-7
spellingShingle Peng Kong
Zi-Yang Cui
Xiao-Fu Huang
Dan-Dan Zhang
Rui-Juan Guo
Mei Han
Inflammation and atherosclerosis: signaling pathways and therapeutic intervention
Signal Transduction and Targeted Therapy
title Inflammation and atherosclerosis: signaling pathways and therapeutic intervention
title_full Inflammation and atherosclerosis: signaling pathways and therapeutic intervention
title_fullStr Inflammation and atherosclerosis: signaling pathways and therapeutic intervention
title_full_unstemmed Inflammation and atherosclerosis: signaling pathways and therapeutic intervention
title_short Inflammation and atherosclerosis: signaling pathways and therapeutic intervention
title_sort inflammation and atherosclerosis signaling pathways and therapeutic intervention
url https://doi.org/10.1038/s41392-022-00955-7
work_keys_str_mv AT pengkong inflammationandatherosclerosissignalingpathwaysandtherapeuticintervention
AT ziyangcui inflammationandatherosclerosissignalingpathwaysandtherapeuticintervention
AT xiaofuhuang inflammationandatherosclerosissignalingpathwaysandtherapeuticintervention
AT dandanzhang inflammationandatherosclerosissignalingpathwaysandtherapeuticintervention
AT ruijuanguo inflammationandatherosclerosissignalingpathwaysandtherapeuticintervention
AT meihan inflammationandatherosclerosissignalingpathwaysandtherapeuticintervention